Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures (ESOGRAFT)
ESOGRAFT
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
In this study the investigators investigate the feasibility and therapeutic potential of free autologous fat grafting combined to dilation therapy in the treatment of benign esophageal strictures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2020
CompletedFirst Posted
Study publicly available on registry
January 9, 2020
CompletedStudy Start
First participant enrolled
August 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedMarch 2, 2021
February 1, 2021
7 months
January 6, 2020
February 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of Treatment-Emergent Adverse Events at 3 months
Types, severity and probability of procedure related adverse events
3 months
Incidence of Treatment-Emergent Adverse Events at 12 months
Types, severity and probability of procedure related adverse events
12 months
Secondary Outcomes (6)
Change from Baseline Eckardt score at 3 months
3 months
Change from Baseline Eckardt-score at 12 months
12 months
Change from Baseline Stricture Lumen diameter at 3 months
3 months
Change from Baseline Stricture Lumen diameter at 12 months
12 months
Change from Baseline Stricture length at 3 months
3 months
- +1 more secondary outcomes
Study Arms (1)
Esophageal stricture patients
EXPERIMENTALPatients suffering from benign esophageal stricture are treated with through-the scope CRE dilation balloon. Free fat graft is gathered from the abdominal subcutaneous fat. Fat graft is prepared and injected to the stricture site.
Interventions
Esophageal stricture is treated by dilation therapy.
Autologous fat graft is gathered and injected to stricture
Eligibility Criteria
You may qualify if:
- Esophageal stricture that has re-occurred at least once
You may not qualify if:
- Malignant etiology of esophageal stricture
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pauliina Hartiala, Surgeon
Turku University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Gastrointestinal surgeon / Consultant in Division of Gastrointestinal Surgery
Study Record Dates
First Submitted
January 6, 2020
First Posted
January 9, 2020
Study Start
August 15, 2021
Primary Completion
March 1, 2022
Study Completion
March 1, 2023
Last Updated
March 2, 2021
Record last verified: 2021-02